A hybrid CFD-PBPK model for naphthalene in rat and human with IVIVE for nasal tissue metabolism and cross-species dosimetry

References

• Abdo KM, Eustis SL, McDonald M, et al. (1992). Naphthalene: a respiratory tract toxicant and carcinogen for mice. Inhal Toxicol 4:393–409
   Google Scholar
• Abdo KM, Grumbein S, Chou BJ, Herbert R. (2001). Toxicity and carcinogenicity study in F344 rats following 2 years of whole-body exposure to naphthalene vapors. Inhal Toxicol 13:931–50
   PubMed Web of Science ®Google Scholar
• Andersen ME, Sarangapani R, Frederick CB, Kimbell JS. (1999). Dosimetric adjustment factors for methylmethacrylate derived from a steady-state analysis of a physiologically based clearance-extraction model. Inhal Toxicol 11:899–923
   PubMed Web of Science ®Google Scholar
• Baldwin RM, Jewell WT, Fanucchi MV, et al. (2004). Comparison of pulmonary/nasal CYP2F expression levels in rodents and Rhesus Macaque. J Pharmacol Exp Ther 309:127–36
   PubMed Web of Science ®Google Scholar
• Baldwin RM, Shultz MA, Buckpitt AR. (2005). Bioactivation of the pulmonary toxicants naphthalene and 1-nitronaphthalene by rat CYP2F4. J Pharmacol Exp Ther 312:857–65
   PubMed Web of Science ®Google Scholar
• Barter ZE, Bayliss MK, Beaune PH, et al. (2007). Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Curr Drug Metab 8:33–45
   PubMed Web of Science ®Google Scholar
• Bogdanffy MS, Sarangapani R, Plowchalk DR, et al. (1999). A biologically-based risk assessment for vinyl acetate-induced cancer and non-cancer inhalation toxicity. Toxicol Sci 51:19–35
   PubMed Web of Science ®Google Scholar
• Bogen KT, Benson JM, Yost GS, et al. (2008). Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action. Reg Tox Pharm 51:27–36
   Web of Science ®Google Scholar
• Brown RP, Delp MD, Lindstedt SL, et al. (1997). Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407–84
   PubMed Web of Science ®Google Scholar
• Buckpitt AR. (2013). Personal communication of experiments provided in a report to the Toxic Substances and Control Division, Department of Health Services, State of California on June 17, 1990
   Google Scholar
• Buckpitt AR, Bahnson LS. (1986). Naphthalene metabolism by human lung microsomal enzymes. Toxicology 41:333–41
   PubMed Web of Science ®Google Scholar
• Buckpitt A, Boland B, Isbell M, et al. (2002). Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev 34:791–820
   PubMed Web of Science ®Google Scholar
• Buckpitt A, Buonarati M, Avey LB, et al. (1992). Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat, and rhesus monkey. J Pharmacol Exp Ther 261:364–72
   PubMed Web of Science ®Google Scholar
• Buckpitt A, Morin D, Murphy S, et al. (2013). Kinetics of naphthalene metabolism in target and non-target tissues of rodents and in nasal and airway microsomes from the Rhesus monkey. Toxicol Appl Pharmacol 270:97–105
   PubMed Web of Science ®Google Scholar
• Cho TM, Rose RL, Hodgson E. (2006). In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes. Drug Metab Disp 34:176–83
   PubMed Web of Science ®Google Scholar
• Clewell RA, Clewell HJ III. (2008). Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Regul Toxicol Pharmacol 50:129–43
   PubMed Web of Science ®Google Scholar
• Dodd DE, Gross EA, Miller RA, Wong BA. (2010). Nasal olfactory epithelial lesions in F344 and SD rats following 1- and 5-day inhalation exposure to naphthalene vapor. Int J Toxicol 29:175–84
   PubMed Web of Science ®Google Scholar
• Dodd DE, Wong BA, Gross EA, Miller RA. (2012). Nasal epithelial lesions in F344 rats following a 90-day inhalation exposure to naphthalene. Inhal Toxicol 24:70–9
   PubMed Web of Science ®Google Scholar
• Farber E. (1984). Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture. Cancer Res 44:5463–74
   PubMed Web of Science ®Google Scholar
• Frederick CB, Bush ML, Lomax LG, et al. (1998). Application of computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways. Toxicol Appl Pharmacol 152:211–31
   PubMed Web of Science ®Google Scholar
• Holmberg K, Bake B, Pipkorn U. (1989). Mucosal blood flow in the human nose following local challenge with histamine. Allergy 44:45–51
   PubMed Web of Science ®Google Scholar
• Iwatsubo T, Suzuki H, Sugiyama Y. (1997). Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data. J Pharmacol Exp Ther 283:462–9
   PubMed Web of Science ®Google Scholar
• Kim D, Andersen ME, Chao YC, et al. (2007). PBTK modeling demonstrates contribution of dermal and inhalation exposure components to end-exhaled breath concentrations of naphthalene. Environ Health Perspect 115:894–901
   PubMed Web of Science ®Google Scholar
• Kimbell JS, Godo MN, Gross EA, et al. (1997). Computer simulation of inspiratory airflow in all regions of the F344 rat nasal passages. Toxicol Appl Pharmacol 145:388–98
   PubMed Web of Science ®Google Scholar
• Lee MG, Phimister A, Morin D, et al. (2005). In situ naphthalene bioactivation and nasal airflow cause region-specific injury patterns in the nasal mucosa of rats exposed to naphthalene by inhalation. J Pharmacol Exp Ther 314:103–10
   PubMed Web of Science ®Google Scholar
• Long PH, Herbert RA, Peckham JC, et al. (2003). Morphology of nasal lesions in F344/N rats following chronic inhalation exposure to naphthalene vapors. Toxicol Pathol 31:655–64
   PubMed Web of Science ®Google Scholar
• Miles PR, Bowman L, Jones WG, et al. (1994). Changes in alveolar lavage materials and lung microsomal xenobiotic metabolism following exposures to HCl-washed or unwashed crystalline silica. Toxicol Appl Pharmacol 129:235–42
   PubMed Web of Science ®Google Scholar
• Morris JB, Buckpitt AR. (2009). Upper respiratory tract uptake of naphthalene. Toxicol Sci 111:383–91
   PubMed Web of Science ®Google Scholar
• Morris JB, Hassett DN, Blanchard KT. (1993). A physiologically based pharmacokinetic model for nasal uptake and metabolism of nonreactive vapors. Toxicol Appl Pharmacol 123:120–9
   PubMed Web of Science ®Google Scholar
• Morris JB, Kimbell JS, Asgharian B. (2010). Upper airway dosimetry of gases, vapors and particulate matter in rodents. In: Morris JB, Shusterman DJ (eds.) Toxicology of the nose and upper airway. New York: Informa Healthcare, 99–115
   Google Scholar
• National Toxicology Program (NTP). (1992). Toxicology and carcinogenesis studies of naphthalene in B6C3F1 mice (inhalation studies). Technical Report Series No 410. NTP, Research Triangle Park, NC
   Google Scholar
• National Toxicology Program (NTP). (2000). Toxicology and carcinogenesis studies of naphthalene (CAS No. 91-20-3) in F344/N rats (Inhalation Studies). Technical Report Series No. 500. NIH Publication No. 01-4434. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC
   Google Scholar
• Paulsson B, Bende M, Ohlin P. (1985). Nasal mucosal blood flow at rest and during exercise. Acta Otolaryngol 99:140–3
   PubMed Web of Science ®Google Scholar
• Pitot HC, Hikita H, Dragan Y, et al. (2000). Review article: the stages of gastrointestinal carcinogenesis – application of rodent models to human disease. Aliment Pharmacol Ther Suppl 1:153–60
   Google Scholar
• Plowchalk DR, Andersen ME, Bogdanffy MS. (1997). Physiologically based modeling of vinyl acetate uptake, metabolism, and intracellular pH changes in the rat nasal cavity. Toxicol Appl Pharmacol 142:386–400
   PubMed Web of Science ®Google Scholar
• Prough RA, Sípal Z, Jakobsson SW. (1977). Metabolism of benzo(a)pyrene by human lung microsomal fractions. Life Sci 21:1629–35
   PubMed Web of Science ®Google Scholar
• Quick DJ, Shuler ML. (1999). Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences. Biotechnol Prog 15:540–55
   PubMed Web of Science ®Google Scholar
• Rietjens IM, Dormans JA, Rombout PJ, van Bree L. (1988). Qualitative and quantitative changes in cytochrome P-450-dependent xenobiotic metabolism in pulmonary microsomes and isolated Clara cell populations derived from ozone-exposed rats. J Toxicol Environ Health 24:515–31
   PubMed Web of Science ®Google Scholar
• Sarangapani R, Teeguarden JG, Cruzan G, et al. (2002). Physiologically based pharmacokinetic modeling of styrene and styrene oxide respiratory-tract dosimetry in rodents and humans. Inhal Toxicol 14:789–834
   PubMed Web of Science ®Google Scholar
• Shultz MA, Choudary PV, Buckpitt AR. (1999). Role of murine cytochrome P-450 2F2 in metabolic activation of naphthalene and metabolism of other xenobiotics. J Pharmacol Exp Ther 290:281–8
   PubMed Web of Science ®Google Scholar
• Subramaniam R, Richardson RB, Morgan KT, et al. (1998). Computational fluid dynamics simulations of inspiratory airflow in the human nose and nasopharynx. Inhal Toxicol 10:91–120
   Web of Science ®Google Scholar
• Teeguarden JG, Bogdanffy MS, Covington TR, et al. (2008). A PBPK model for evaluating the impact of aldehyde dehydrogenase polymorphisms on comparative rat and human nasal tissue acetaldehyde dosimetry. Inhal Toxicol 20:375–90
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency (USEPA). (1994). Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry EPA/600/8-90/066F. Office of Health and Environmental Assessment, USEPA, Washington, DC
   Google Scholar
• U.S. Environmental Protection Agency (USEPA). (1996). Soil Screening Guidance: User's Guide. Office of Solid Waste and Emergency Response. Publication 9355.4-23. Washington, DC
   Google Scholar
• U.S. Environmental Protection Agency (USEPA). (2009). STATUS REPORT: Advances in Inhalation Dosimetry of Gases and Vapors with Portal of Entry Effects in the Upper Respiratory Tract. EPA/600/R-09/072. Office of Health and Environmental Assessment, USEPA, Washington, DC
   Google Scholar
• Warren DL, Brown DL, Buckpitt AR. (1982). Evidence for cytochrome P-450 mediated metabolism in the bronchiolar damage by naphthalene. Chem Biol Interact 40:287–303
   PubMed Web of Science ®Google Scholar
• Willems BAT, Melnick RL, Kohn MC, Portier CJ. (2001). A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and mice. Toxicol Appl Pharmacol 176:81–91
   PubMed Web of Science ®Google Scholar
• Yoon M, Madden MC, Barton HA. (2006). Developmental expression of aldehyde dehydrogenase in rat: a comparison of liver and lung development. Toxicol Sci 89:368–98
   Web of Science ®Google Scholar